Association Between the Development of Thrombosis and Worsening of Disease Severity in Patients With Moderate COVID-19 on Admission ― From the CLOT-COVID Study ―
-
- Ikeda Satoshi
- Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences
-
- Ueno Yuki
- Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences
-
- Maemura Koji
- Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences
-
- Yachi Sen
- Japan Community Health Care Organization Tokyo Shinjuku Medical Center
-
- Takeyama Makoto
- Japan Community Health Care Organization Tokyo Shinjuku Medical Center
-
- Nishimoto Yuji
- Hyogo Prefectural Amagasaki General Medical Center
-
- Tsujino Ichizo
- Hokkaido University Hospital
-
- Nakamura Junichi
- Hokkaido University Hospital
-
- Yamamoto Naoto
- Hamamatsu Medical Center
-
- Nakata Hiroko
- Yokosuka General Hospital Uwamachi
-
- Umetsu Michihisa
- Tohoku University Hospital
-
- Aikawa Shizu
- Tsukuba Medical Center Hospital
-
- Hayashi Hiroya
- Osaka City University Graduate School of Medicine
-
- Satokawa Hirono
- Fukushima Medical University, School of Medicine
-
- Okuno Yoshinori
- Kyoto University Hospital
-
- Iwata Eriko
- Nankai Medical Center Japan Community Health Care Organization
-
- Ogihara Yoshito
- Mie University Hospital
-
- Ikeda Nobutaka
- Toho University Ohashi Medical Center
-
- Kondo Akane
- Shikoku Medical Center for Children and Adults
-
- Iwai Takehisa
- Tsukuba Vascular Center
-
- Yamada Norikazu
- Kuwana City Medical Center
-
- Ogawa Tomohiro
- Fukushima Daiichi Hospital
-
- Kobayashi Takao
- Hamamatsu Medical Center
-
- Mo Makoto
- Yokohama Minami Kyosai Hospital
-
- Yamashita Yugo
- Kyoto University Hospital
この論文をさがす
説明
<p>Background: The worsening of coronavirus disease 2019 (COVID-19) severity is a critical issue in current clinical settings and may be associated with the development of thrombosis.</p><p>Methods and Results: This study used patient data obtained in the CLOT-COVID study, a retrospective multicenter cohort study. The demographics of patients with moderate COVID-19 on admission with and without worsened severity during hospitalization were compared and predictors were identified. Of 927 patients with moderate COVID-19 on admission, 182 (19.6%) had worsened severity during hospitalization. Patients with worsening of severity were older, more likely to have hypertension, diabetes, heart disease, and active cancer, and more likely to use pharmacological thromboprophylaxis. Patients with worsening of severity had higher D-dimer levels on admission and were more likely to develop thrombosis and major bleeding during hospitalization than those without worsening. Increased age (odds ratio [OR]: 1.02, 95% confidence interval [CI]: 1.01–1.03, P=0.005), diabetes (OR: 1.63, 95% CI: 1.11–2.33, P=0.012), D-dimer levels >1.0 μg/mL on admission (OR: 2.10, 95% CI: 1.45–3.03, P<0.001), and thrombosis (OR: 6.28, 95% CI: 2.72–14.53, P<0.001) were independently associated with worsening of COVID-19 severity.</p><p>Conclusions: Approximately 20% of patients with moderate COVID-19 had worsened severity during hospitalization. Increased age, diabetes, D-dimer levels >1.0 μg/mL on admission, and the development of thrombosis during hospitalization were significantly associated with worsened COVID-19 severity.</p>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 87 (3), 448-455, 2023-02-24
一般社団法人 日本循環器学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390858164827166336
-
- NII書誌ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- NDL書誌ID
- 032684035
-
- PubMed
- 35786694
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
-
- 抄録ライセンスフラグ
- 使用不可